US start-up Colossal Biosciences says it is on track to produce a woolly mammoth calf born to a surrogate elephant mother by ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

A biotechnology company whose goal is to bring back the wooly mammoth says its recent small step is big news. Colossal ...

Recreating a woolly mammoth calf by 2028 is the extraordinary promise US-based genetic engineering company Colossal Biosciences is striving towards. As the clock ticks down, its scientists have ...

The company said it’s on track to produce a woolly mammoth calf born to a surrogate elephant mother by late 2028.

The company said it’s on track to produce a woolly mammoth calf born to a surrogate elephant mother by late 2028. “Woolly Mouse is not just a feat of engineering,” said chief executive and ...

which leads to a mammoth calf. Pictured is Colossal's "woolly mouse" next to a wild-type mouse. Dallas-based biotech startup Colossal aims to bring the woolly mammoth back from extinction through ...

"It's like reverse Jurassic Park," Lamm said. Colossal is aiming to bring back a woolly mammoth calf, born to a surrogate elephant mother, by late 2028. On the path to reviving the mammoth ...

Scientists at Colossal Biosciences, a US biotechnology company, have recently announced that they have successfully created ...

The recent funding from TWG Global reflects investor confidence in the company's ambitious plans to utilize genetic technology for the de-extinction of the woolly mammoth and other species ...